AMD (AMD) Q2 2025 earnings review
China Export Ban Hits Margins, But Strong Guidance Signals Accelerating Momentum Elsewhere
AMD reported a record Q2 revenue of $7.7 billion (+32% YoY), driven by a massive 69% surge in the Client & Gaming segment. However, this top-line strength was overshadowed by a regulatory shock: new U.S. export controls on MI308 AI accelerators for China. This forced an $800M inventory charge, causing GAAP operating income to collapse to a loss of $134M and slashing non-GAAP EPS by 30% YoY to $0.48. Despite this significant headwind, management issued strong Q3 guidance for $8.7B revenue (+13% QoQ) and a return to 54% non-GAAP gross margin, signaling that demand for its AI and CPU portfolio outside of China is accelerating significantly.
🐂 Bull Case
The robust Q3 revenue guidance of $8.7B (+13% sequentially) is particularly strong as it excludes the impacted China business, implying the core portfolio (MI350, EPYC, Ryzen) is growing at a much faster rate.
The Client & Gaming segment grew a massive 69% YoY, with record Client CPU sales and strong semi-custom demand. This demonstrates powerful momentum from the new 'Zen 5' product cycle and provides a significant profit offset to Data Center weakness.
🐻 Bear Case
The China export ban is no longer a hypothetical risk. It directly led to an $800M charge, wiped out Data Center profitability for the quarter, and creates significant uncertainty about future regulatory actions on other high-performance products.
The Data Center segment, previously the primary growth driver, saw YoY growth decelerate sharply to 14% (from 57% in Q1) and declined 12% sequentially. This breaks the segment's strong growth trend and makes the company more reliant on the cyclical Client segment.
⚖️ Verdict: ⚪
Mixed. The underlying business momentum ex-China appears very strong, reflected in the impressive Q3 guidance. However, the materialization of geopolitical risk is a serious negative that has immediately impacted profitability and introduces significant uncertainty. The bull case relies on flawless execution of the MI350 and Ryzen ramp, while the bear case of regulatory risk is now a painful reality.
Key Themes
Geopolitical Shock: China Export Ban Wipes Out Profit
The new U.S. export control on MI308 accelerators to China had an immediate and severe impact. AMD took an $800M inventory and related charge, which directly caused the Data Center segment to post a $(155)M operating loss, a stunning reversal from a $932M profit in Q1. This single event reduced Q2 non-GAAP EPS by an estimated $0.43. The guidance for Q3 excludes any MI308 revenue to China, formalizing the loss of this market for the product and highlighting the significant geopolitical risk in the high-end semiconductor business.
Client & Gaming Segment Fires on All Cylinders
The combined Client & Gaming segment was the standout performer, with revenue surging 69% YoY to $3.6B. This was driven by record Client revenue of $2.5B (+67% YoY) from strong demand for the latest 'Zen 5' Ryzen processors and a richer product mix. Gaming revenue also jumped 73% YoY. The segment's operating income exploded to $767M from $166M a year ago, providing a crucial offset to the Data Center's troubles.
Underlying AI & CPU Demand Appears Robust Ex-China
Despite the China setback, the strong Q3 guidance points to accelerating demand elsewhere. Guiding for $8.7B revenue (+13% QoQ) after removing the China MI308 business implies the core portfolio is growing much faster than the headline rate. The guided return to a 54% non-GAAP gross margin also suggests that the profitability of the upcoming MI350 AI accelerator ramp and ongoing EPYC CPU sales is strong enough to absorb the hit.
Data Center Growth Trend Reverses
The Data Center segment's 14% YoY growth is a sharp deceleration from 57% in Q1 and 122% in Q3 of last year. More concerning is the 12% sequential decline. This contradicts the press release narrative that strong EPYC processor demand 'more than offset' the MI308 headwind on a sequential basis. This break in the segment's powerful growth trajectory is a major point of concern for what was the company's primary growth engine.
EPYC Server CPUs Maintain Momentum
The narrative of 'record server processor sales' highlights the ongoing strength of the EPYC franchise. The company noted it now powers 172 supercomputers on the Top500 list, including the top two. New deployments for 5G infrastructure with partners like KDDI and Nokia underscore continued market share gains in both cloud and enterprise, providing a stable foundation for the Data Center segment.
Embedded Segment Remains Stagnant
The Embedded segment continues to be a laggard, with revenue down 4% YoY. While it has seemingly bottomed and is flat sequentially, it is not contributing to growth. Management's commentary that 'demand in end markets remained mixed' indicates there is no near-term catalyst for a sharp recovery.
Strategic Divestiture to Sharpen Focus
The announced definitive agreement to sell ZT Systems’ data center infrastructure manufacturing business to Sanmina for $3 billion is a significant strategic move. It allows AMD to focus on its core competencies of silicon, software, and systems design while partnering with a manufacturing specialist. This should sharpen operational focus and improve capital allocation.
Other KPIs
Trend is Accelerating. AMD generated a record $1.18B in Free Cash Flow, up significantly from $439M YoY and $727M QoQ. This demonstrates strong operational execution and working capital management, providing ample flexibility for R&D investments and capital returns despite the inventory charge, which is a non-cash expense for the period.
Trend is Reversing. The segment's operating margin collapsed from +25% in Q1 2025 and +21% a year ago to -5% this quarter. This dramatic reversal is a direct result of the $800M inventory charge. The path back to strong positive margins depends entirely on a successful ramp of the new MI350 series and continued strength in EPYC sales.
Inventories rose 4% sequentially from $6.42B. While this includes the written-down MI308 inventory, the increase in stock ahead of a strongly guided Q3 is reasonable but warrants monitoring to ensure it aligns with sell-through and doesn't become a future headwind.
Guidance
Sequentially Accelerating. The midpoint implies 28% YoY growth (a slight deceleration from 32% in Q2) but a strong 13% QoQ growth (a significant acceleration from 3% in Q2). This sequential acceleration is very positive as it comes *after* removing the China MI308 business, indicating powerful momentum in the rest of the portfolio.
Reversing. This guidance marks a full recovery from the 43% reported in Q2. It signals a return to the stable underlying margin profile seen over the past year and suggests the profitability of the new product mix (MI350, EPYC, high-end Ryzen) is strong.
Key Questions
Quantifying the 'Ex-China' Business Momentum
Can you provide more color on the implied sequential growth rate for the Data Center segment in Q3 if we were to exclude the MI308 China revenue from the Q2 baseline? This would help us understand the true underlying momentum of the MI350 and EPYC ramps.
MI308 Inventory Strategy
What are the plans for the $800M of MI308 inventory that was written down? Is there any possibility of selling this product to other unrestricted markets, or should we consider this a total loss?
Client Segment Sustainability
Client revenue growth of 67% was spectacular. How much of this was channel fill for new Zen 5 products versus end demand, and how should we think about the sustainability of this growth rate into the second half of the year?
EPYC Growth vs. MI308 Decline
The Data Center segment declined 12% sequentially. Can you help us understand the magnitude of the EPYC growth versus the MI308 decline within that number? Specifically, did EPYC processor revenue grow sequentially in Q2?
Future Regulatory Risk Mitigation
Beyond the MI308, what is your assessment of the risk of further U.S. export controls on other products, such as the new MI350 series, and what steps are you taking to mitigate this geopolitical risk across your product roadmap?